Zymeworks Inc.
ZYME
$23.90
-$0.13-0.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -4.25% | -90.89% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -4.25% | -90.89% | |||
| Cost of Revenue | 10.32% | -12.21% | |||
| Gross Profit | -11.59% | -260.62% | |||
| SG&A Expenses | -2.35% | 9.09% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.13% | -6.15% | |||
| Operating Income | -6.72% | -99.69% | |||
| Income Before Tax | -11.75% | -127.08% | |||
| Income Tax Expenses | -711.48% | -120.21% | |||
| Earnings from Continuing Operations | -7.17% | -110.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.17% | -110.23% | |||
| EBIT | -6.72% | -99.69% | |||
| EBITDA | -6.76% | -109.51% | |||
| EPS Basic | -8.12% | -111.44% | |||
| Normalized Basic EPS | -12.76% | -128.33% | |||
| EPS Diluted | -8.23% | -109.66% | |||
| Normalized Diluted EPS | -12.73% | -128.33% | |||
| Average Basic Shares Outstanding | -0.89% | -0.57% | |||
| Average Diluted Shares Outstanding | -0.85% | -0.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||